United Therapeutics: Strong Catalyst Flow Bodes Well For Near-Term Growth

United Therapeutics: Strong Catalyst Flow Bodes Well For Near-Term Growth

United Therapeutics gets a reiterated “buy” rating on upcoming PDUFA dates and other catalysts that could drive future growth. Click here to read more on UTHR.